Pure Global

Glycosylated hemoglobin Determination kit - India CDSCO Medical Device Registration

Glycosylated hemoglobin Determination kit is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2022/000246_9123408f12c333d24df74119e3602d86_98b0d35f3f18ae199824913cf5173978. This device is marketed under the brand name hba1c. The license holder is Allied Biotechnology India Pvt. Ltd., and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class B
Glycosylated hemoglobin Determination kit
UID: IMP/IVD/2022/000246_9123408f12c333d24df74119e3602d86_98b0d35f3f18ae199824913cf5173978

Brand Name

hba1c

Device Class

Class B

Approving Authority

CDSCO

Product Information

The reagents are used for quantitative determination of glycosylated hemoglobin in human whole blood in vitro

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing